Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24 h after acute exposure to the drug

Neuropharmacology

Volumn 55, Issue 7, 2008, Pages 1172-1182

  Kouvaras, E ^a   Asprodini, E K ^a   Asouchidou, I ^a   Vasilaki, A ^a   Kilindris, T ^a   Michaloudis, D ^a   Koukoutianou, I ^a   Papatheodoropoulos, C ^b   Kostopoulos, G ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Electrophysiology; Fentanyl; GABA; Hippocampus; Immunohistochemistry; Inhibition

Indexed keywords

4 AMINOBUTYRIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; BICUCULLINE METHOCHLORIDE; FENTANYL; SODIUM CHLORIDE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; GABAERGIC TRANSMISSION; HIPPOCAMPUS; MALE; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

2-AMINO-5-PHOSPHONOVALERATE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANALGESICS, OPIOID; ANIMALS; BICUCULLINE; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; FENTANYL; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; NEURONAL PLASTICITY; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, GABA-B;

EID: 54049096240     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.07.025     Document Type: Article

References (53)

1. Asensio V.J., Miralles J.A., and Sevilla G. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by μ-, δ- and κ-opioid receptor antagonists in the rat brain: regulation by chronic morphine and opioid withdrawal. Eur. J. Pharmacol. 539 (2006) 49-56
2. Azaralosa J.L., Stitzer M.L., and Greenwald M.K. Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history. Psychopharmacology (Berl.) 114 (1994) 71-80
3. Bickel W.K., Stitzer M.L., Liebson A., and Bigelow G.E. Acute physical dependence in man: effects of naloxone after brief morphine exposure. J. Pharmacol. Exp. Ther. 244 (1988) 126-132
4. Bjorkman S., Stanski D.R., Harashima H., Dowrie R., Harapat S.R., Wada D.R., and Ebling W.F. Tissue distribution of fentanyl and alfentanyl in the rat cannot be described by a blood flow limited model. J. Pharmacokin. Biopharm. 21 (1993) 255-279
5. Bowers G., Cullinan W.E., and Herman J.P. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. J. Neurosci. 18 (1998) 5938-5947
6. Capogna M., Gahwiler B.H., and Thompson S.M. Mechanism of μ-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. 470 (1993) 539-558
7. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., and Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
8. Celerier E., Simonnet G., and Maldonado R. Prevention of fentanyl-induced delayed pronociceptive effects in mice lacking the protein kinase Cγ gene. Neuropharmacology 46 (2004) 264-272
9. Davies S.N., and Collingridge G.L. Role of excitatory amino acid receptors in synaptic transmission in area CA1 of rat hippocampus. Proc. R. Soc. Lond. B Biol. Sci. 236 (1989) 373-384
10. Dingledine R. Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons. J. Neurosci. 1 (1981) 1022-1035
11. Drake C.T., and Milner T.A. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res. 849 (1999) 203-215
12. Fan Y., Zou B., Ruan Y., Pang Z., and Xu Z.C. In vivo demonstration of a late depolarizing postsynaptic potential in CA1 pyramidal neurons. J. Neurophysiol. 93 (2005) 1326-1335
13. Fukuda T., Aika Y., Heizman C.W., and Kosaka T. GABAergic axon terminals at the perisomatic and dendritic inhibitory sites show different immunoreactivities against two GAD isoforms, GAD 67 and GAD 65, in the mouse hippocampus: a digitized quantitative analysis. J. Comp. Neurol. 395 (1998) 177-194
14. Gol A., and Faibisch G.M. Hippocampectomy for relief of intractable pain. Tex. Med. 62 (1966) 76-79
15. Gray J.A., and McNaughton N. The Neurophysiology of Anxiety (2000), Oxford UP, Oxford
16. Guera D., Sole A., Cami J., and Tobena A. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend. 20 (1987) 261-270
17. Guo M., Xu N., Li Y., Yang J., Wu C., and Pei G. Morphine modulates glutamate release in the hippocampal CA1 area in mice. Neurosci. Lett. 381 (2005) 12-15
18. Haas H.L., and Ryall R.W. Is excitation by enkephalins of hippocampal-neurons in the rat due to presynaptic facilitation or to disinhibition?. J. Physiol. (Lond.) 308 (1980) 315-330
19. Harris A.C., Hanes S.L., and Gewirtz J.C. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Psychopharmacology (Berl.) 176 (2004) 266-273
20. Harris A.C., and Gewritz J.C. Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal. Psychopharmacology 178 (2005) 353-366
21. Hebben N., Corkin S., Eichenbaum H., and Shedlack K. Diminished ability to interpret and report internal states after bilateral medial temporal resection: case H.M. Behav. Neurosci. 99 (1985) 1031-1039
22. Houser C.R., and Esclapez M. Localization of mRNAs encoding two forms of glutamate acid decarboxylase in the rat hippocampal formation. Hippocampus 4 (1994) 530-545
23. Hug Jr. C.C., and Murphy M.R. Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology 55 (1981) 369-375
24. Liu J., and Schulteis G. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Pharmacol. Biochem. Behav. 79 (2004) 101-108
25. Lupica C.R., Proctor W.R., and Dunwiddie T.V. Dissociation of mu-opioid and delta-opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Brain Res. 593 (1992) 226-238
26. McKenna J.E., and Melzack R. Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain 49 (1992) 105-112
27. McKenna J.E., and Melzack R. Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp. Neurol. 172 (2001) 92-99
28. Mansouri F.A., Motamedi F., and Fathollahi Y. Chronic in vitro morphine administration facilitates primed-bursts-induced long-term potentiation of Schaffer collateral CA1 synapses in hippocampal slices in vitro. Brain Res. 815 (1999) 419-423
29. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100 (2002) 213-217
30. Moises H.C., Rusin K.I., and McDonald R.L. Mu and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium currents in rat dorsal root ganglion sensory neurons. J. Neurosci. 14 (1994) 5903-5916
31. Murphy D.D., Cole N.B., Greenberger V., and Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18 (1998) 2550-2569
32. Murphy M.R., Hug Jr. C.C., and McCain D.A. Dose-independent pharmacokinetics of fentanyl. Anesthesiology 59 (1983) 537-540
33. Nicoll R.A., Alger B.E., and Jahr C.E. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287 (1980) 22-25
34. Papatheodoropoulos C., Asprodini E., Nikita I., Koutsona C., and Kostopoulos G. Weaker synaptic inhibition in the CA1 region of ventral compared to dorsal rat hippocampal slices. Brain Res. 948 (2002) 117-121
35. B receptors on glutamatergic terminals of CA1 pyramidal cells decrease in efficacy after partial hippocampal kindling. Synapse 59 (2006) 125-134
36. Pu L., Bao G.B., Xu N.J., and Pei G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J. Neurosci. 22 (2002) 1914-1921
37. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., and Reisine T. Pharmacological characterization of the cloned kappa-, delta- and mu-opioid receptors. Mol. Pharmacol. 45 (1993) 330-334
38. Salmanzadeh F., Fathollahi Y., Semnanian S., and Shafizadeh M. Dependence on morphine impairs the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Brain Res. 965 (2003) 108-113
39. Schulteis G., Morse A.C., and Liu J. Conditioning process contribute to severity of naloxone precipitated withdrawal from acute opioid dependence. Psychopharmacology 175 (2004) 463-472
40. Shaw-Lutcham T.Z., Barrit M., Wallace T., Gilden L., Zachariou V., Impy S., Duman R.S., Storm D., and Nestler E.L. Regional and cellular maping of Camp response element-mediated transcription during naltrexone precipitated morphine withdrawal. J. Neurosci. 22 (2002) 3663-3672
41. Siggins G.R., and Zieglgansberger W. Morphine and opioid peptides reduce inhibitory post synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. Proc. Natl. Acad. Sci. USA 78 (1981) 5235-5239
42. Sinclair J.G., and Lo G.F. Morphine, but not atropine, blocks nociceptor-driven activity in rat dorsal hippocampal neurones. Neurosci. Lett. 68 (1986) 47-50
43. Song P., and Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neurosci. Res. 39 (2001) 281-286
44. Stumm R.K., Zhou C., Schulz S., and Hollt V. Neuronal types expressing μ- and δ-opioid receptor mRNA in the rat hippocampal formation. J. Comp. Neurol. 469 (2004) 107-118
45. Svoboda K.R., and Lupica C.R. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J. Neurosci. 18 (1998) 7084-7098
46. Swearengen E., and Chavkin C. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat. Neuropharmacology 28 (1989) 689-697
47. Vasilaki A., Gardette R., Epelbaum J., and Thermos K. NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1600-1609
48. Wei F., Xu Z.C., Qu Z., Milbrandt J., and Zhuo M. Role of EGR1 in hippocampal synaptic enhancement induced by tetanic stimulation and amputation. J. Cell Biol. 149 (2000) 1325-1334
49. White-Gbadebo D., and Holtzman S.G. Acute sensitization to opioid antagonists. Pharmacol. Biochem. Behav. 47 (1994) 559-566
50. Wigstrom H., and Gustafsson B. Facilitated induction of long-lasting potentiation during blockade of inhibition. Nature 301 (1983) 603-605
51. Wimpey T.L., Caudle R.M., and Chavkin C. Chronic morphine exposure blocks opioid effects on both the early and late inhibitory postsynaptic potentials in hippocampal CA1 pyramidal cells. Neurosci. Lett. 110 (1990) 349-355
52. Xu N.-J., Bao L., Fan H.-P., Bao G.-B., Pu L., Lu Y.-J., Wu C.-F., Zhang X., and Gang P. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporters GLT1 at hippocampal synapses. J. Neurosci. 23 (2003) 4775-4784
53. Zieglegansberger W., French E.D., Siggins G.R., and Bloom F.E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205 (1979) 415-417